cyclosporine and Chronic Hepatitis C

cyclosporine has been researched along with Chronic Hepatitis C in 80 studies

Research

Studies (80)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (2.50)	18.2507
2000's	34 (42.50)	29.6817
2010's	41 (51.25)	24.3611
2020's	3 (3.75)	2.80

Authors

Authors	Studies
Adianti, M; Aoki-Utsubo, C; Hafid, AF; Hotta, H; Permanasari, AA; Tumewu, L; Wahyuni, TS; Widyawaruyanti, A	1
Huber, AD; Ji, J; Liu, D; Michailidis, E; Ndongwe, TP; Ralston, R; Rice, CM; Sarafianos, SG; Tedbury, PR	1
De Simone, C; Garcovich, M; Garcovich, S; Gnarra, M	1
Frey, A; Gerken, G; Herzer, K; Piras-Straub, K; Timm, J; Walker, A	1
Hashimoto, S; Hayashi, K; Nakagawa, Y; Saito, K; Takahashi, K; Takamura, M; Takeuchi, S; Tanabe, Y; Tasaki, M; Terai, S; Tomita, Y; Yamagiwa, S; Yoshida, T	1
Muzica, C; Sfarti, C; Stanciu, C; Trifan, A	1
El-Hamamsy, M; El-Meteini, M; Mansy, AE; Montasser, IF; Nabet, DE	1
Haga, I; Kawagishi, N; Nakamura, A; Takayama, T	1
Gerken, G; Herzer, K; Jochum, C; Papadopoulos-Köhn, A; Paul, A; Timm, J	1
Baugh, J; Brass, CA; Chatterji, U; Gallay, PA; Garcia-Rivera, JA; Gawlik, K; Naoumov, NV; Wong, KA; Zhong, W	1
Fukuhara, T; Ikegami, T; Itoh, S; Kato, M; Maehara, Y; Matsuura, Y; Nakamura, S; Shirabe, K; Yamamoto, S; Yoshizumi, T	1
Bitetto, D; Bulajic, M; Cmet, S; Cussigh, A; Fabris, C; Falleti, E; Toniutto, P; Vadalà, S; Zilli, M	1
Antonini, TM; Bonhomme-Faivre, L; Coilly, A; Duclos-Vallée, JC; Furlan, V; Haim-Boukobza, S; Roque-Afonso, AM; Samuel, D; Sebagh, M; Taburet, AM; Teicher, E; Vittecoq, D	1
Alberti, A; Brass, C; Buti, M; Calistru, P; Chuang, WL; Davis, GL; Flisiak, R; Goeser, T; Horban, A; Kao, JH; Mazzella, G; Orsenigo, R; Pol, S; Rasenack, J; Streinu-Cercel, A; Tabak, F	1
Bellissant, E; Boglione-Kerrien, C; Boudjema, K; Dermu, M; Jezequel, C; Lemaitre, F; Verdier, MC	1
Bernhardt, P; Duvoux, C; Firpi, RJ; Grazi, GL; Levy, G; Mulhaupt, B; Pageaux, G; Rauer, B; Renner, EL; Schirm, F; Villamil, F	1
Chen, CJ; Cheng, TT; Lin, JC; Lin, KM	1
Chagas, C; Lebre, L; Machado, D; Magalhães-Costa, P	1
Abaalkhail, F; Al Hamoudi, W; Al Sebayel, M; Al-Kattan, W; Broering, D; Elsiesy, H; Selim, K; Yousif, S	1
Avila, C; Chuang, WL; Flisiak, R; Foster, GR; Hézode, C; Li, B; Naoumov, NV; Pawlotsky, JM; Peng, CY; Piratvisuth, T; Rasenack, J; Sarin, SK; Shah, S; Wedemeyer, H; Wong, KA; Zhang, W	1
Abdurakhmanov, D; Bao, W; Brass, C; Buggisch, P; Calistru, P; Flisiak, R; Gould, M; Griffel, LH; Heo, J; Hsu, SJ; Makara, M; Mazur, W; Mazzella, G; Merz, M; Mutimer, D; Naoumov, NV; Nault, B; Samuel, D; Stanciu, C; Thongsawat, S; Van Kính, N; Vierling, JM; Zeuzem, S	1
Bo, Q; Brass, C; Griffel, L; Orsenigo, R; Wang, J	1
Crabbé, R; Cuypers, L; Kerremans, L; Libin, P; Snoeck, J; Van Dooren, S; Vandamme, AM; Vuagniaux, G	1
Chighizola, CB; Meroni, PL; Ong, VH	1
Alves, R; Figueiredo, A; Leal, R; Pinto, H	1
Aikata, H; Chayama, K; Imamura, M; Ishiyama, K; Kawakami, Y; Kawaoka, T; Morio, K; Nakamura, Y; Nelson Hayes, C; Ochi, H; Ohdan, H; Tsuge, M	1
Andreone, P; Berenguer, M; Calleja, JL; Cieciura, T; Donato, MF; Durlik, M; Fagiuoli, S; Forns, X; Herzer, K; Janssen, K; Jessner, W; Kalmeijer, R; Lenz, O; Mariño, Z; Ouwerkerk-Mahadevan, S; Peeters, M; Shukla, U; Sterneck, M; Verbinnen, T	1
Barbosa, DV; Carvalho-Filho, RJ; Ferraz, ML; Lanzoni, VP; Narciso-Schiavon, JL; Schiavon, LL; Silva, AE	1
Kato, M; Miura, H; Ryu, T; Saito, T; Yamada, H	1
Bazzani, C; Benucci, M; Caporali, R; Galeazzi, M; Giannitti, C; Manganelli, S; Scarpato, S; Sebastiani, GD	1
Fuchinoue, S; Imaizumi, R; Nakajima, I; Nanmoku, K; Sakamoto, N; Teraoka, S; Tojimbara, T; Watanabe, M	1
Baliellas, C; Castellote, J; Fabregat, J; Figueras, J; Garcia-Gil, A; Lladó, L; Rafecas, A; Ramos, E; Serrano, T; Torras, J; Xiol, X	1
Crabbé, R; Dumont, JM; Marfurt, J; Nicolas-Métral, V; Novaroli, L; Vuagniaux, G	1
Bellisai, F; Ferri, C; Galeazzi, M; Giannitti, C	1
Altomare, A; Altomare, G; Colombo, DM; Franchi, C; Frigerio, E; Garutti, C; Spadino, S	1
Crabbé, R; Feinman, SV; Flisiak, R; Grosgurin, P; Heathcote, JE; Horban, A; Jablkowski, M; Kryczka, W; Liz, JS; Mazzella, G; Nicolas-Métral, V; Pawlowska, M; Porchet, H; Scalfaro, P; Vandelli, C	1
Elewski, BE; Gottlieb, AB; Lebwohl, M; Rosmarin, DM	1
Albertini, G; Di Lernia, V	1
Di Lernia, V; Guareschi, E	1
Di Lernia, V	1
Dechêne, A; Gerken, G; Hilgard, P; Kahraman, A; Miller, M; Pütter, C; Ross, SR; Scherag, A; Witzke, O	1
Bebo, BF; Frankel, A; Gottlieb, A; Hsu, S; Korman, NJ; Lebwohl, M; Van Voorhees, AS	1
Arcona, S; Bowers, D; Irish, WD; Trotter, JF	1
Ballarin, R; Cautero, N; Cocchi, S; Codeluppi, M; D'Amico, G; De Ruvo, N; Di Benedetto, F; Gerunda, GE; Guaraldi, G; Guerrini, GP; Iemmolo, RM; Mimmo, A; Montalti, R; Rompianesi, G; Serra, V; Smerieri, N; Spaggiari, M; Tarantino, G	1
Berenguer, M	1
Forns, X; Navasa, M	1
Trotter, JF	1
Hokari, A	1
Kato, N; Muroyama, R	1
Ferenci, P	1
Gao, M; Lin, K; Liu, Q; Villareal, VA; Yang, PL	1
Antonini, TM; Barau, C; Bonhomme-Faivre, L; Coilly, A; Duclos-Vallée, JC; Furlan, V; Noël, C; Roche, B; Roque-Afonso, AM; Samuel, D; Taburet, AM	1
Everson, GT	1
Inoue, K; Sekiyama, K; Watanabe, T; Yamada, M; Yasuda, H; Yoshiba, M	1
Durand, D; Izopet, J; Kamar, N; Ribes, D; Rostaing, L; Sandres-Saune, K	1
Bismuth, J; Canet, S; Chong, G; Garrigue, V; Lesnik, A; Mourad, G; Taourel, P	1
Michaelis, HC; Rockstroh, JK; Sauerbruch, T; Spengler, U; Sudhop, T; Türler, A; Vogel, M; Voigt, E; Wolff, M	1
Fabregat, J; Figueras, J; Lladó, L; Rafecas, A; Ramos, E; Rufí, G; Serrano, T; Torras, J; Xiol, X	1
Pollard, S	1
Nishioka, K; Yamamoto, T; Yokozeki, H	1
Davis, GL	1
Abdelmalek, MF; Cabrera, R; Firpi, RJ; Liu, C; Machicao, VI; Morelli, G; Nelson, DR; Reed, AI; Soldevila-Pico, C; Zhu, H	1
De Mattia, D; De Santis, A; Francavilla, R; Gentile, A; Martire, B	1
Baba, HA; Beckebaum, S; Broelsch, CE; Gerken, G; Hilgard, P; Kahraman, A; Lehmann, N; Malago, M; Ross, RS; Seltmann, C	1
Durand, D; Izopet, J; Kamar, N; Rostaing, L; Sandres-Saune, K; Selves, J	1
Riely, CA; Shokouh-Amiri, MH; Tombazzi, CR; Vera, SR; Waters, B	1
Abraham, JL; Boyd, AS; Zic, JA	1
Bellisai, F; Donvito, A; Galeazzi, M; Giannitti, C	1
Furue, M; Imafuku, S; Tashiro, A	1
Aoudjehane, L; Batteux, F; Calmus, Y; Conti, F; Dharancy, S; Podevin, P; Rosenberg, AR; Soubrane, O	1
Bravi, M; Bruni, F; Candusso, M; Colledan, M; Fagiuoli, S; Gaffuri, G; Torre, G	1
Dudley, T; Haydon, G; Mutimer, D; Nightingale, P; Oo, YH	1
Ferenci, P; Gangl, A; Peck-Radosavljevic, M; Rasoul-Rockenschaub, S; Reiberger, T; Rieger, A	1
Akiyama, H; Hiruma, K; Kohara, M; Onozawa, Y; Sakamaki, H; Tanaka, T; Tanikawa, S; Wakita, T; Yoshinaga, H	1
Berenguer, J; Berenguer, M; Carrasco, D; Córdoba, J; Gobernado, M; Mir, J; Olaso, V; Prieto, M; Rayón, JM; San-Juan, F	1
Cisterne, JM; Durand, D; Izopet, J; Puel, J; Rostaing, L; Sandres, K	1
Dequiedt, P; Fontaine, P; Guillem, P; Pruvot, FR; Vlaeminck-Guillem, V	1
Inoue, K; Yoshiba, M	1
Geller, DA; Tsoulfas, G	1

Reviews

16 review(s) available for cyclosporine and Chronic Hepatitis C

Article	Year
Efficacy and safety of alisporivir for the treatment of hepatitis C infection. Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:4 Topics: Antiviral Agents; Cyclosporine; Hepacivirus; Hepatitis C, Chronic; Humans; Treatment Outcome	2019
The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review. Clinical reviews in allergy & immunology, 2017, Volume: 52, Issue:3 Topics: Adult; Arthritis, Juvenile; Behcet Syndrome; Child; Cyclosporine; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Activation; Rheumatology; Sjogren's Syndrome; Still's Disease, Adult-Onset; T-Lymphocytes; Virus Replication	2017
Treatment of rheumatic diseases in patients with HCV and HIV infection. Autoimmunity reviews, 2008, Volume: 8, Issue:2 Topics: Antibodies; Cyclosporine; Hepatitis C, Chronic; HIV Infections; Humans; Rheumatic Diseases; Tumor Necrosis Factor-alpha	2008
An evaluation of the cyclophilin inhibitor Debio 025 and its potential as a treatment for chronic hepatitis C. Expert opinion on investigational drugs, 2009, Volume: 18, Issue:2 Topics: Animals; Antiviral Agents; Cyclophilins; Cyclosporine; Hepatitis C, Chronic; Humans	2009
Treatment strategies for a patient with rheumatoid arthritis and hepatitis C. Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:4 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Prognosis; Receptors, Tumor Necrosis Factor; Treatment Outcome; Tumor Necrosis Factor-alpha	2009
Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference. Journal of the American Academy of Dermatology, 2010, Volume: 62, Issue:5 Topics: Adolescent; Adult; Animals; Child; Contraindications; Cyclosporine; Drug Interactions; Female; Hepatitis C, Chronic; HIV Infections; Humans; Hypertension; Kidney Diseases; Pregnancy; Psoriasis	2010
[Improved virologic response in chronic hepatitis C treated with peginterferon, ribavirin and add-on drug]. Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69 Suppl 4 Topics: Antiviral Agents; Cyclosporine; Diterpenes; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fatty Alcohols; Female; Fluvastatin; Hepatitis C, Chronic; Humans; Indoles; Interferon-alpha; Male; Metformin; Nitro Compounds; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Silybin; Silymarin; Thiazoles	2011
Treatment of chronic hepatitis C--are interferons really necessary? Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32 Suppl 1 Topics: Antiviral Agents; Carbamates; Cyclophilins; Cyclosporine; Drug Substitution; Hepatitis C, Chronic; Humans; Imidazoles; Immunologic Factors; Interferon-alpha; Polyethylene Glycols; Pyrrolidines; Recombinant Proteins; Serine Proteinase Inhibitors; Sofosbuvir; Uridine Monophosphate; Valine	2012
Anti-HCV drugs in the pipeline. Current opinion in virology, 2011, Volume: 1, Issue:6 Topics: Animals; Antiviral Agents; Carbamates; Cyclosporine; Deoxycytidine; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Pyrrolidines; Valine; Virus Replication	2011
Impact of immunosuppressive therapy on recurrence of hepatitis C. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2002, Volume: 8, Issue:10 Suppl 1 Topics: Cyclosporine; Disease Progression; Glucocorticoids; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Muromonab-CD3; Mycophenolic Acid; Receptors, Interleukin-2; Recurrence; Risk Assessment; Sirolimus; Tacrolimus	2002
[Nocardiosis--is it frequently observed after the introduction of new immunosuppressive agents in renal transplantation?]. Nephrologie, 2004, Volume: 25, Issue:2 Topics: Adrenal Cortex Hormones; Adult; Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Complications; Disease Susceptibility; Female; Graft Rejection; Hepatitis C, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Nocardia asteroides; Nocardia Infections; Postoperative Complications; Reoperation; Risk Factors; Tacrolimus; Trimethoprim, Sulfamethoxazole Drug Combination	2004
Calcineurin inhibition and disease recurrence in the hepatitis C virus-positive liver transplant recipient. Liver international : official journal of the International Association for the Study of the Liver, 2004, Volume: 24, Issue:5 Topics: Calcineurin Inhibitors; Cyclosporine; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Postoperative Complications; Recurrence; Virus Replication	2004
Gadolinium deposition in nephrogenic fibrosing dermopathy. Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:1 Topics: Acidosis; Aged; Blood Vessels; Bone Marrow Cells; Calcium Phosphates; Contrast Media; Cyclosporine; Electron Probe Microanalysis; Female; Fibrosis; Gadolinium; Hepatitis C, Chronic; Humans; Hypocalcemia; Kidney Failure, Chronic; Liver Failure; Magnetic Resonance Imaging; Microscopy, Electron, Scanning; Models, Biological; Phosphates; Postoperative Complications; Renal Dialysis; Skin; Skin Diseases	2007
Cyclosporin in steroid-resistant autoimmune hepatitis and HCV-related liver diseases. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2007, Volume: 39 Suppl 3 Topics: Adrenal Cortex Hormones; Cyclosporine; Drug Resistance; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents	2007
[IFN combined cyclosporin A therapy]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:7 Topics: Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferons; Treatment Outcome	2001
NF-kappaB in transplantation: friend or foe? Transplant infectious disease : an official journal of the Transplantation Society, 2001, Volume: 3, Issue:4 Topics: Adenoviridae; Animals; Cyclosporine; Gene Expression Regulation; Genetic Therapy; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oligodeoxyribonucleotides; Organ Transplantation; Reperfusion Injury; Signal Transduction; Sulfasalazine; Tacrolimus	2001

Trials

10 trial(s) available for cyclosporine and Chronic Hepatitis C

Article	Year
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial. Journal of viral hepatitis, 2015, Volume: 22, Issue:7 Topics: Adult; Aged; Antiviral Agents; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Placebos; Ribavirin; Salvage Therapy; Treatment Outcome; Viral Load; Young Adult	2015
Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection. Annals of transplantation, 2015, Jan-15, Volume: 20 Topics: Adolescent; Adult; Aged; Antiviral Agents; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tacrolimus; Treatment Outcome; Young Adult	2015
Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection. Hepatology (Baltimore, Md.), 2015, Volume: 62, Issue:4 Topics: Adult; Antiviral Agents; Cyclosporine; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2015
Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II). Alimentary pharmacology & therapeutics, 2015, Volume: 42, Issue:7 Topics: Adolescent; Adult; Aged; Antiviral Agents; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; United States; Young Adult	2015
HCV1b genome evolution under selective pressure of the cyclophilin inhibitor alisporivir during the DEB-025-HCV-203 phase II clinical trial. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2016, Volume: 44 Topics: Antiviral Agents; Cyclosporine; Drug Resistance, Viral; Genome, Viral; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Phylogeny; Polyethylene Glycols; Recombinant Proteins; Viral Load; Viral Nonstructural Proteins	2016
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study. Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:3 Topics: Adult; Aged; Antiviral Agents; Carbamates; Cyclosporine; Drug Therapy, Combination; Female; Genotype; Graft Rejection; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; RNA, Viral; Simeprevir; Tacrolimus; Treatment Outcome; Valine; Viral Load	2017
Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: results of a prospective randomized study. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2008, Volume: 14, Issue:12 Topics: Adult; Antibodies, Monoclonal; Basiliximab; Cyclosporine; Evolution, Molecular; Female; Glucocorticoids; Graft Rejection; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Prospective Studies; Recombinant Fusion Proteins; Secondary Prevention	2008
The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients. Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:5 Topics: Adult; Aged; Antiviral Agents; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Viral Load; Young Adult	2009
Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial. Journal of gastroenterology, 2003, Volume: 38, Issue:6 Topics: Alanine Transaminase; Antiviral Agents; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polymerase Chain Reaction; Recombinant Proteins; RNA, Viral; Safety; Time Factors; Viral Load	2003
Amantadine therapy in renal transplant patients with hepatitis C virus infection. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2004, Volume: 30, Issue:1 Topics: Adult; Alanine Transaminase; Amantadine; Antiviral Agents; Aspartate Aminotransferases; Cyclosporine; Hepatitis C, Chronic; Humans; Immunocompromised Host; Kidney Transplantation; Liver; Middle Aged; RNA, Viral; Viral Load; Viremia	2004

Other Studies

54 other study(ies) available for cyclosporine and Chronic Hepatitis C

Article	Year
An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs. BMC complementary medicine and therapies, 2021, Oct-12, Volume: 21, Issue:1 Topics: Antiviral Agents; Artocarpus; Cell Line; Cyclosporine; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Indonesia; Oligopeptides; Plant Extracts; Plant Leaves; Ribavirin	2021
Mechanisms of Action of the Host-Targeting Agent Cyclosporin A and Direct-Acting Antiviral Agents against Hepatitis C Virus. Viruses, 2023, 04-17, Volume: 15, Issue:4 Topics: Antiviral Agents; Cyclosporine; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Viral Nonstructural Proteins	2023
Low-Dose Cyclosporine A in the Treatment of Severe Atopic Dermatitis Complicated by Chronic Hepatitis C Virus Infection. Pediatric dermatology, 2017, Volume: 34, Issue:3 Topics: Adolescent; Cyclosporine; Dermatitis, Atopic; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Male; Tacrolimus	2017
The influence of immunosuppressants on direct-acting antiviral therapy is dependent on the hepatitis C virus genotype. Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:1 Topics: Antiviral Agents; Benzimidazoles; Calcineurin Inhibitors; Carbamates; Cell Line; Cyclosporine; Everolimus; Fluorenes; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Imidazoles; Immunosuppressive Agents; Liver Transplantation; Pyrrolidines; Sirolimus; Sofosbuvir; Valine; Virus Replication	2018
Ombitasvir-Paritaprevir-Ritonavir Therapy in a Kidney Transplant Recipient With Chronic Hepatitis C Virus Genotype 1 Infection: A Case Report on the Importance of Considering Drug-Drug Interactions and Monitoring Cyclosporine Levels. Transplantation proceedings, 2018, Volume: 50, Issue:3 Topics: Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Kidney Transplantation; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Proline; Ribavirin; Ritonavir; Sulfonamides; Valine	2018
Effect of cyclosporine A versus tacrolimus on the response to antiviral therapy after hepatitis C genotype-4 recurrence post-liver transplantation: A prospective cohort trial. Journal of clinical pharmacy and therapeutics, 2019, Volume: 44, Issue:3 Topics: Adult; Aged; Antiviral Agents; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Ribavirin; Sofosbuvir; Tacrolimus; Young Adult	2019
Safety of Direct-Acting Antiviral Therapy for Renal Function in Post-Kidney Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response: A Single-Center Study. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2020, Volume: 24, Issue:2 Topics: Adult; Aged; Antiviral Agents; Cyclosporine; Female; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Sustained Virologic Response; Tacrolimus; Treatment Outcome	2020
[HCV reinfection after liver transplantation - management and first experiences with telaprevir-based triple therapy]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:36 Topics: Adult; Antiviral Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; Tacrolimus; Viral Load	2013
The combination of alisporivir plus an NS5A inhibitor provides additive to synergistic anti-hepatitis C virus activity without detectable cross-resistance. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6 Topics: Antiviral Agents; Cyclophilin A; Cyclophilins; Cyclosporine; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Replicon; Viral Nonstructural Proteins; Virus Replication	2014
Reduced-dose telaprevir-based triple antiviral therapy for recurrent hepatitis C after living donor liver transplantation. Transplantation, 2014, Nov-15, Volume: 98, Issue:9 Topics: Aged; Anemia; Antiviral Agents; Cohort Studies; Cyclosporine; End Stage Liver Disease; Female; Glomerular Filtration Rate; Haplotypes; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; High-Throughput Nucleotide Sequencing; Humans; Japan; Liver Transplantation; Living Donors; Male; Middle Aged; Mutation; Oligopeptides; Recurrence; RNA, Viral; Treatment Outcome	2014
Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated. International journal of surgery (London, England), 2014, Volume: 12, Issue:10 Topics: Adult; Aged; Anastomotic Leak; Cholestasis; Cyclosporine; Female; Genetic Variation; Genotype; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferons; Interleukins; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Tacrolimus	2014
Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation. AIDS (London, England), 2015, Jan-02, Volume: 29, Issue:1 Topics: Adult; Antiviral Agents; Coinfection; Cyclosporine; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Immunosuppression Therapy; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Recurrence; Ribavirin; Tacrolimus; Viral Load	2015
Lack of drug interaction between cyclosporine and telaprevir in a liver transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:1 Topics: Cyclosporine; Drug Interactions; Drug Monitoring; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Oligopeptides; Serine Proteinase Inhibitors; Transplant Recipients	2015
Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study. Clinical rheumatology, 2015, Volume: 34, Issue:6 Topics: Adalimumab; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Hepatitis C, Chronic; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha	2015
Lack of impact of hepatitis C virus infection on graft survival after kidney transplantation--a Portuguese single-center experience. Transplantation proceedings, 2015, Volume: 47, Issue:4 Topics: Adult; Age Factors; Aged; Azathioprine; Cardiovascular Diseases; Case-Control Studies; Cyclosporine; Female; Graft Rejection; Graft Survival; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Portugal; Proportional Hazards Models; Renal Dialysis; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome	2015
Spontaneous clearance of hepatitis C genotype 4 after liver retransplantation. Transplantation proceedings, 2015, Volume: 47, Issue:4 Topics: Adult; Cyclosporine; Female; Genotype; Graft Rejection; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Recurrence; Remission, Spontaneous; Reoperation; RNA, Viral	2015
Glucose abnormalities in Asian patients with chronic hepatitis C. Drug design, development and therapy, 2015, Volume: 9 Topics: Adult; Age Factors; Antiviral Agents; Asian People; Blood Glucose; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclosporine; Diabetes Mellitus, Type 2; Female; Hepatitis C, Chronic; Humans; Interferons; Logistic Models; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Ribavirin; Risk Factors; Sex Factors; Treatment Outcome	2015
Late spontaneous decapsulation of the kidney graft in a patient with hepatitis C and treated with sirolimus: possible pathophysiological association in a rare complication. BMJ case reports, 2017, Jan-18, Volume: 2017 Topics: Antiviral Agents; Cyclosporine; Drug Substitution; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prednisolone; Risk Factors; Sirolimus; Tomography, X-Ray Computed	2017
Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantation. Clinical journal of gastroenterology, 2017, Volume: 10, Issue:2 Topics: Aged; Antiviral Agents; Benzimidazoles; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Female; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Recurrence; RNA, Viral; Sofosbuvir; Viral Load	2017
Impact of cyclosporine-based immunosuppressive therapy on liver histology of hepatitis C virus-infected renal transplant patients. Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:1 Topics: Cyclosporine; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver; Liver Transplantation	2008
[Peginterferon alfa-2b and ribavirin-induced pure red cell aplasia during treatment of chronic hepatitis C treated by cyclosporin A with good response]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2008, Jul-10, Volume: 97, Issue:7 Topics: Administration, Inhalation; Antiviral Agents; Cyclosporine; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Red-Cell Aplasia, Pure; Ribavirin	2008
Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy. Transplantation proceedings, 2008, Volume: 40, Issue:7 Topics: Alanine Transaminase; Cyclosporine; Disease Progression; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Immunosuppressive Agents; Japan; Kidney Transplantation; Postoperative Complications; Retrospective Studies; RNA, Viral; Tacrolimus; Virus Replication	2008
Hepatitis C viral load decreases after cyclosporin treatment for erosive lichen planus. Clinical and experimental dermatology, 2009, Volume: 34, Issue:7 Topics: Aged; Antiviral Agents; Cyclosporine; Dermatologic Agents; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Lichen Planus; Viral Load	2009
Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: risk or opportunity? Journal of the American Academy of Dermatology, 2010, Volume: 63, Issue:2 Topics: Cyclosporine; Dermatologic Agents; Hepatitis C, Chronic; Humans; Practice Guidelines as Topic; Psoriasis; Risk Factors	2010
Successful treatment of hand and foot psoriasis with infliximab. Dermatology online journal, 2010, Jul-15, Volume: 16, Issue:7 Topics: Adult; Antibodies, Monoclonal; Cyclosporine; Dermatologic Agents; DiGeorge Syndrome; Fatty Liver, Alcoholic; Female; Foot Dermatoses; Hand Dermatoses; Hepatitis C, Chronic; Humans; Infliximab; Male; Methotrexate; Middle Aged; Psoriasis; Retinoids; Retrospective Studies; Treatment Outcome	2010
Treatment of psoriasis in patients with hepatitis C virus infection. Clinical and experimental dermatology, 2011, Volume: 36, Issue:4 Topics: Acitretin; Antiviral Agents; Cyclosporine; Drug Eruptions; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Methotrexate; Psoriasis; Ribavirin	2011
Impact of immunosuppressive therapy on hepatitis C infection after renal transplantation. Clinical nephrology, 2011, Volume: 75, Issue:1 Topics: Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Female; Germany; Graft Survival; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Retrospective Studies; RNA, Viral; Tacrolimus; Time Factors; Transaminases; Treatment Outcome; Viral Load; Virus Replication	2011
In response to "Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: risk or opportunity?". Journal of the American Academy of Dermatology, 2011, Volume: 64, Issue:4 Topics: Cyclosporine; Dermatologic Agents; Evidence-Based Medicine; Hepatitis C, Chronic; Humans; Psoriasis; Risk Factors	2011
Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN database. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2011, Volume: 11, Issue:8 Topics: Adult; Cohort Studies; Cyclosporine; Database Management Systems; Female; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Proportional Hazards Models; Tacrolimus; Treatment Outcome	2011
University of Modena experience in HIV-positive patients undergoing liver transplantation. Transplantation proceedings, 2011, Volume: 43, Issue:4 Topics: Adult; Antiretroviral Therapy, Highly Active; Carcinoma, Hepatocellular; CD4 Lymphocyte Count; Cyclosporine; Drug Substitution; End Stage Liver Disease; Female; Graft Rejection; Graft Survival; Hepatitis C, Chronic; HIV; HIV Infections; Hospitals, University; Humans; Immunosuppressive Agents; Italy; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; RNA, Viral; Severity of Illness Index; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome; Viral Load	2011
Hot topic in hepatitis C virus research: the type of immunosuppression does not matter. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2011, Volume: 17 Suppl 3 Topics: Antiviral Agents; Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Receptors, Interleukin-2; Recurrence; Risk Factors; Tacrolimus; TOR Serine-Threonine Kinases	2011
Cyclosporine a-based immunosuppression reduces relapse rate after antiviral therapy in transplanted patients with hepatitis C virus infection: a large multicenter cohort study. Transplantation, 2011, Aug-15, Volume: 92, Issue:3 Topics: Antiviral Agents; Cohort Studies; Cyclosporine; Female; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Secondary Prevention	2011
Cyclosporine A or tacrolimus for hepatitis C recurrence? An old debate. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2011, Volume: 11, Issue:8 Topics: Cyclosporine; Database Management Systems; Female; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Tacrolimus; Treatment Outcome	2011
Hot-topic debate on hepatitis C virus: the type of immunosuppression matters. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2011, Volume: 17 Suppl 3 Topics: Adrenal Cortex Hormones; Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Recurrence; Risk Factors; Sirolimus	2011
[New antivirals against hepatitis C virus(protease inhibitors, polymerase inhibitors, and host factor targeting antivirals)]. Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69 Suppl 4 Topics: Antiviral Agents; Cyclosporine; Hepacivirus; Hepatitis C, Chronic; Humans; Protease Inhibitors; RNA-Dependent RNA Polymerase	2011
Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11 Topics: Aged; Antiviral Agents; Cyclosporine; Disease Management; Drug Therapy, Combination; Everolimus; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Proline; Recombinant Proteins; Recurrence; Ribavirin; Sirolimus; Tacrolimus; Viral Load	2012
Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2004, Volume: 10, Issue:7 Topics: Adult; Cyclosporine; Drug Interactions; Hepatitis C, Chronic; HIV Protease Inhibitors; HIV Seropositivity; Humans; Liver Transplantation; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir	2004
Liver transplantation without steroid induction in HIV-infected patients. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2004, Volume: 10, Issue:10 Topics: Adult; AIDS-Related Opportunistic Infections; Antibodies, Monoclonal; Antiretroviral Therapy, Highly Active; Basiliximab; Contraindications; Cyclosporine; Hepatitis C, Chronic; HIV Infections; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Recombinant Fusion Proteins; Spain; Steroids	2004
Evaluation of psoriatic patients with HCV infection. The Journal of dermatology, 2005, Volume: 32, Issue:9 Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Etretinate; Evaluation Studies as Topic; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Psoriasis; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome	2005
The challenge of progressive hepatitis C following liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006, Volume: 12, Issue:1 Topics: Cyclosporine; Disease Progression; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; In Vitro Techniques; Liver Failure; Liver Transplantation; Postoperative Complications; Recurrence; Sensitivity and Specificity	2006
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006, Volume: 12, Issue:1 Topics: Adult; Cyclosporine; Follow-Up Studies; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; In Vitro Techniques; Liver Failure; Liver Transplantation; Middle Aged; Postoperative Complications; Retrospective Studies; Secondary Prevention; Tacrolimus; Treatment Outcome	2006
Successful treatment with cyclosporine A of HCV-driven chronic liver disease mimicking autoimmune hepatitis in a patient with common variable immunodeficiency. Immunopharmacology and immunotoxicology, 2005, Volume: 27, Issue:4 Topics: Child; Common Variable Immunodeficiency; Cyclosporine; Female; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver	2005
Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis. World journal of gastroenterology, 2006, Feb-07, Volume: 12, Issue:5 Topics: Adult; Cohort Studies; Cyclosporine; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; RNA, Viral; Tacrolimus; Virus Replication	2006
Does cyclosporine have a beneficial effect on the course of chronic hepatitis C infection after renal transplantation? Transplantation proceedings, 2006, Volume: 38, Issue:5 Topics: Adult; Cyclosporine; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney Transplantation; Male; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Viral Load	2006
Neuropsychiatric complications after liver transplantation: role of immunosuppression and hepatitis C. Digestive diseases and sciences, 2006, Volume: 51, Issue:6 Topics: Adult; Aged; Cyclosporine; Depressive Disorder; Female; Hepatitis C, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Incidence; Liver Diseases; Liver Transplantation; Male; Medical Records; Middle Aged; Postoperative Complications; Retrospective Studies; Tacrolimus; Tennessee	2006
Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection. Clinical rheumatology, 2007, Volume: 26, Issue:7 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Hepatitis C, Chronic; Humans; Immunoglobulin G; Immunosuppressive Agents; Liver Function Tests; Male; Middle Aged; Receptors, Tumor Necrosis Factor; Treatment Outcome; Tumor Necrosis Factor-alpha	2007
Ciclosporin treatment of psoriasis in a patient with chronic hepatitis C. The British journal of dermatology, 2007, Volume: 156, Issue:6 Topics: Antiviral Agents; Cyclosporine; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Psoriasis; Recombinant Proteins	2007
Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation. Transplantation, 2007, Apr-15, Volume: 83, Issue:7 Topics: Adrenal Cortex Hormones; Adult; Biopsy; Cyclosporine; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interleukin-2; Interleukin-4; Liver Transplantation; Male; Middle Aged; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tacrolimus; Transcription, Genetic	2007
Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2008, Volume: 14, Issue:1 Topics: Adult; Aged; Biopsy; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Diseases, Alcoholic; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Tacrolimus; Treatment Outcome	2008
Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection. European journal of clinical investigation, 2008, Volume: 38, Issue:6 Topics: Adult; Aged; Antiviral Agents; Calcineurin Inhibitors; CD4 Lymphocyte Count; Cyclosporine; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Immunocompromised Host; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Prognosis; Recombinant Proteins; Retrospective Studies; Ribavirin; Statistics, Nonparametric; Tacrolimus; Treatment Outcome; Viral Load	2008
Effects of cyclosporin A on hepatitis C virus infection in bone marrow transplant patients. Bone Marrow Transplantation Team. Bone marrow transplantation, 1997, Volume: 20, Issue:11 Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Hepacivirus; Hepatitis Antibodies; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Remission, Spontaneous; Viral Nonstructural Proteins	1997
Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. Journal of hepatology, 1998, Volume: 28, Issue:5 Topics: Alanine Transaminase; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Genome, Viral; Graft Rejection; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Prednisone; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Time Factors	1998
Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil. Transplantation, 2000, Mar-15, Volume: 69, Issue:5 Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Gene Dosage; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Osmolar Concentration; RNA, Viral; Time Factors; Viremia	2000
Liver transplantation eliminates insulin needs of a diabetic patient. Diabetes & metabolism, 2000, Volume: 26, Issue:6 Topics: Aged; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Glomerulonephritis; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Insulin; Kidney Failure, Chronic; Liver Transplantation; Middle Aged; Postoperative Period	2000